CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
-1.4%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$94.2M
AUM Growth
+$94.2M
(-8.1%)
Cap. Flow
-$6.52M
Cap. Flow
% of AUM
-6.92%
Top 10 Holdings %
Top 10 Hldgs %
45.23%
Holding
75
New
2
Increased
22
Reduced
9
Closed
10
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$910K |
| 2 |
PagerDuty
PD
|
$900K |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$890K |
| 4 |
Evolus
EOLS
|
$686K |
| 5 |
Freeport-McMoran
FCX
|
$597K |
Top Sells
| 1 |
CVS Health
CVS
|
$1.38M |
| 2 |
American Superconductor
AMSC
|
$1.13M |
| 3 |
SWN
Southwestern Energy Company
SWN
|
$1.13M |
| 4 |
Amneal Pharmaceuticals
AMRX
|
$853K |
| 5 |
Autodesk
ADSK
|
$818K |
Sector Composition
| 1 | Healthcare | 38.49% |
| 2 | Financials | 9.8% |
| 3 | Industrials | 9.03% |
| 4 | Energy | 8.36% |
| 5 | Materials | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Coya Therapeutics
COYA
$112M
| $384K | 0.41% |
100,000
+40,000
| +67% | +$154K |
|
52
Femasys
FEMY
$12M
| $373K | 0.4% |
125,000
-116,373
| -48% | -$347K |
|
53
Smith Micro Software
SMSI
$15.2M
| $363K | 0.39% |
300,000
+75,000
| +33% | +$90.8K |
|
|
KRON
54
DELISTED
Kronos Bio
KRON
| $325K | 0.34% |
250,000
| – | – |
|
55
Eledon Pharmaceuticals
ELDN
$155M
| $322K | 0.34% |
234,803
| – | – |
|
56
Gain Therapeutics
GANX
$69M
| $295K | 0.31% |
90,000
| – | – |
|
57
Edesa Biotech
EDSA
$17.2M
| $264K | 0.28% |
417,602
+42,602
| +11% | +$26.9K |
|
58
Organon & Co
OGN
$2.56B
| $260K | 0.28% |
15,000
| – | – |
|
59
BioCardia
BCDA
$11.8M
| $258K | 0.27% |
600,000
+257,000
| +75% | +$110K |
|
60
Lantern Pharma
LTRN
$46.3M
| $256K | 0.27% |
75,000
| – | – |
|
61
Cadence Bank
CADE
$6.97B
| $212K | 0.23% |
10,000
| – | – |
|
|
PVLA
62
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $194K | 0.21% |
649,400
+99,400
| +18% | +$29.6K |
|
63
Curis
CRIS
$21.5M
| $181K | 0.19% |
27,500
-522,500
| -95% | – |
|
64
NeueHealth
NEUE
$60.6M
| $154K | 0.16% |
25,715
| – | – |
|
|
BCEL
65
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $91.4K | 0.1% |
350,000
| – | – |
|
|
SPPI
66
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| – | – |
-800,000
| Closed | -$768K |
|
|
PRTK
67
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – |
-250,000
| Closed | -$553K |
|
|
NBSE
68
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| – | – |
-6,000
| Closed | -$11K |
|
69
Newell Brands
NWL
$2.64B
| – | – |
-30,000
| Closed | -$261K |
|
70
Cytokinetics
CYTK
$5.98B
| – | – |
-10,000
| Closed | -$326K |
|
|
71
CVS Health
CVS
$93B
| – | – |
-20,000
| Closed | -$1.38M |
|
72
Applied Therapeutics
APLT
$73.7M
| – | – |
-300,000
| Closed | -$384K |
|
73
APA Corp
APA
$8.11B
| – | – |
-20,000
| Closed | -$683K |
|
|
74
Amneal Pharmaceuticals
AMRX
$3B
| – | – |
-275,000
| Closed | -$853K |
|
|
75
Autodesk
ADSK
$67.9B
| – | – |
-4,000
| Closed | -$818K |
|